Patients with Crohn's disease (CD) have an increased risk of small bowel adenocarcinoma (SBA). Long duration of CD is the main risk factor. SB dysplasia has been associated with SBA in 20% of cases, always described in diseased sites. The progression to neoplasia and natural history remains unknown but progression of inflammation to dysplasia and then to adenocarcinoma is suspected. As for surveillance recommendations for colorectal carcinoma in long standing inflammatory colonic disease, endoscopic screening of SB could be proposed in CD patients with risk factors of SBA. No study can be found in literature. The investigators propose a multicenter exploratory open study on prospective cohort of CD patients with high risk of dysplasia or cancer. The goal is evaluate the rate of dysplasia and adenocarcinoma detected by enteroscopy with biopsies in a high risk CD population
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Enrollment
107
endoscopic enteroscopy to do biopsies on jejunum
Chu Amiens
Amiens, France
Chu Besancon
Besançon, France
Hopital Beaujon
Clichy, France
Hopital Bicetre
Le Kremlin-Bicêtre, France
Chru Lille
Lille, France
CHU NICE
Nice, France
Hopital Saint Louis
Paris, France
Institut Mutualiste Montsouris (Imm)
Paris, France
Hopital Haut Leveque
Pessac, France
CHU LYON
Pierre-Bénite, France
...and 5 more locations
Frequency of dysplasia and adenocarcinoma
dysplasia will be described as high or low level Samples will be analysed by 2 different team of anapathologists
Time frame: 2 months
Success of endoscopic detection
the success will be measured by reaching at least one pathologic area during the endoscopic procedure
Time frame: 1-3 Months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.